Recommendation of the President – Verzenios (abemaciclib)

On 22 January 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 8/2025 on the appraisal Verzenios (abemaciclib) as part of the drug program “Treatment of patients with breast cancer (ICD-10: C50)”

Publication in Public Information Bulletin (BIP) >>